Genomic Vision SA
PAR:GV

Watchlist Manager
Genomic Vision SA Logo
Genomic Vision SA
PAR:GV
Watchlist
Price: 0.0018 EUR
Market Cap: €694.6k

Operating Margin

-789%
Current
Declining
by 96.2%
vs 3-y average of -692.8%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-789%
=
Operating Income
€-8.7m
/
Revenue
€1.1m

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-789%
=
Operating Income
€-8.7m
/
Revenue
€1.1m

Peer Comparison

Country Company Market Cap Operating
Margin
FR
Genomic Vision SA
PAR:GV
693.2k EUR
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
US
Abbvie Inc
NYSE:ABBV
393.1B USD
Loading...
US
Amgen Inc
NASDAQ:AMGN
185.9B USD
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
172.7B USD
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
120.7B USD
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
78.5B USD
Loading...
AU
CSL Ltd
ASX:CSL
88.1B AUD
Loading...
NL
argenx SE
XBRU:ARGX
43.4B EUR
Loading...
US
Seagen Inc
F:SGT
39.3B EUR
Loading...

Market Distribution

Lower than 95% of companies in France
Percentile
5th
Based on 2 333 companies
5th percentile
-789%
Low
-17 526.7% — 1.3%
Typical Range
1.3% — 11.5%
High
11.5% — 89 700%
Distribution Statistics
France
Min -17 526.7%
30th Percentile 1.3%
Median 6.1%
70th Percentile 11.5%
Max 89 700%

Genomic Vision SA
Glance View

Market Cap
694.6k EUR
Industry
Biotechnology

Génomic Vision SA is a molecular diagnostics and technology company, which develops and commercializes research tools and tests for the early detection of cancers and genetic diseases. The company is headquartered in Bagneux, Ile-De-France. The company went IPO on 2014-04-02. The company develops and commercializes single-DNA molecule diagnostic tests and research tools for life sciences, cancer and genetic diseases. The firm uses the molecular combining technique for the direct visualization of single DNA molecules to detect quantitative and qualitative changes in the genome landscape and establish their contribution to pathology. The company develops its products and services in three main markets: the medical diagnostic market focusing on DNA diagnostics (cancer genomics, genetic diseases); the pharmaceutical research and development market in the fields of genomics, to develop tests that can help physicians identify how patients are likely to respond to targeted therapies (personalized medicine, pharmacogenomics, cancer cell proliferation); and the academic laboratories research market, providing molecular combining tools for academic research in the field of cancer genetics, cytogenetics and DNA replication.

GV Intrinsic Value
Not Available
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-789%
=
Operating Income
€-8.7m
/
Revenue
€1.1m
What is Genomic Vision SA's current Operating Margin?

The current Operating Margin for Genomic Vision SA is -789%, which is below its 3-year median of -692.8%.

How has Operating Margin changed over time?

Over the last 3 years, Genomic Vision SA’s Operating Margin has decreased from -288.9% to -789%. During this period, it reached a low of -789% on Jul 30, 2023 and a high of -288.9% on May 30, 2020.

Back to Top